Back to search

Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review

Data up to Jan 2025

Published1999
Citations554
References29
Clinical Trials (1)

Total Citations Per Year

Abstract

References (29)

Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin

1995 • 2,330 citations

Low-Molecular-Weight Heparins

1997 • 1,529 citations

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

1997 • 1,447 citations

Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin

1988 • 1,321 citations

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1997 • 1,090 citations

Maternal and fetal sequelae of anticoagulation during pregnancy

1980 • 984 citations

Use of Antithrombotic Agents During Pregnancy

1995 • 682 citations

Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin

1993 • 381 citations

Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.

1994 • 364 citations

Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart Valves

1986 • 294 citations

Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk

1997 • 265 citations

Thromboprophylaxis with Low Molecular Weight Heparin (Fragmin) in High Risk Pregnancies

1997 • 242 citations

Risks to the Fetus of Anticoagulant Therapy During Pregnancy

1989 • 221 citations

Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration

1985 • 191 citations

Use of Low Molecular Weight Heparin in Pregnancy

1992 • 183 citations

Placental transport of heparin

1965 • 169 citations

Subcutaneous Heparin Compared with Continuous Intravenous Heparin Administration in the Initial Treatment of Deep Vein Thrombosis

1992 • 155 citations

Bone density studies in pregnant women receiving heparin

1996 • 125 citations

Bone mineral density during long-term prophylaxis with heparin in pregnancy

1994 • 123 citations

Pharmacokinetics of low molecular weight heparins.

1990 • 82 citations

Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy

1992 • 77 citations

Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma

1989 • 71 citations

Heparin-Induced Thrombocytopenia With Thrombosis and Hemorrhage

1981 • 71 citations

Low Molecular Weight Heparin for Thromboprophylaxis during Pregnancy in 2 Patients with Mechanical Mitral Valve Replacement

1996 • 60 citations

Use of a Low-Molecular Weight Heparin (Enoxaparin) or of a Phenformin-like Substance (Moroxydine Chloride) in Primary Early Recurrent Aborters with an Impaired Fibrinolytic Capacity

1995 • 50 citations

Primary pulmonary hypertenson in pregnancy: A case report

1995 • 33 citations

Low Molecular Weight Heparin as Thromboprophylaxis in Familial Thrombophilia during the Whole Period of Pregnancy

1996 • 20 citations

Low molecular weight heparin and asa therapy in women with autoantibodies and unexplained recurrent fetal loss (U-RFL)

1997 • 8 citations

Effects of 17 β estradiol and progesterone on isolated human omental artery from premenopausal nonpregnant women, and from normal and preeclamptic pregnant women

1995 • 5 citations

Cited By (0)

Loading...
Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review (1999) – Thrombosis and Haemostasis | Metascience Observatory Explorer